Popular Articles

Foresight Biotherapeutics Announces Initiation Of Viral Conjunctivitis Clinical Trial
Foresight Biotherapeutics announced that the first patient has been dosed in a viral conjunctivitis clinical trial. Foresight"s proprietary lead compound, FST-100, will be tested in a placebo-controlled, masked, and randomized multicenter clinical study throughout the United States. The primary endpoint of the study is the resolution of clinical signs and symptoms of acute conjunctivitis. Secondary endpoints include a reduction in quantitative PCR (qPCR) viral titers, eradication of infectious virus determined by cell culture immunofluorescence assay (CC-IFA), and safety. The company anticipates enrolling up to 100 patients.
generic viagra online
Research Reveals Two In Three UK Women Don't Know How To Get Pregnant
Research conducted for Clearblue, the UK"s leading brand in home pregnancy and fertility testing, has revealed that two in three UK women don"t know there is only a small window of opportunity (two "peak" fertile days) in which they can conceive each month . Instead, many women wrongly believe that they can fall pregnant at any point in the month.
News of the day
800th Implant Of World's Only Approved Total Artificial Heart Performed By Heart And Diabetes Center NRW
On June 12, the Heart and Diabetes Center NRW in Bad Oeynhausen, Germany, performed the 800th implant of the SynCardia temporary CardioWest™ Total Artificial Heart. The 60-year-old patient, who was suffering from biventricular failure, was listed in stable condition post-implant.
Health Insurance

When Managing Low-Risk Patients With Chest Pain In The Emergency Department, Cardiac CT Is More Cost Effective

The use of cardiac CT for low-risk chest pain patients in the emergency department, instead of the traditional standard of care (SOC) workup, may reduce a patient"s length of stay and hospital charges, according to a study performed at the University of Washington School of Medicine, Seattle, WA. The SOC workup, which is timely and expensive, consists of a series of cardiac enzyme tests, ECGs and nuclear stress testing. Fifty patients were included in the study. "We found that cardiac CT based workups in low risk chest pain patients decreased the length of hospital stay up to 20 hours and was significantly cheaper (44% less) than using the standard of care workup," said Janet May, MS, lead author of the study. "The SOC mean length of stay was 25.4 hours and the mean length of stay for cardiac CT with observation was 14.3 hours. The mean charges for SOC were $7,597; the mean charges for cardiac CT with observation were $6,153; and the mean charges for cardiac CT without observation were $4,251," said May. "Delivering care through emergency departments is expensive, so cost containment in that setting is critical. Over six million patients present to US emergency rooms each year with chest pain and up to 79% of those patients fall into the low-risk category," she said. "Our study shows that cardiac CT has the potential to significantly reduce cost and length of stay in the emergency department by rapidly identifying those patients who can safely be discharged quickly," said May. This study appears in the July issue of the American Journal of Roentgenology. Heather Curry American Roentgen Ray Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):